A COMBINATION OF OSTEOCLAST DIFFERENTIATION FACTOR AND MACROPHAGE-COLONY-STIMULATING FACTOR IS SUFFICIENT FOR BOTH HUMAN AND MOUSE OSTEOCLAST FORMATION IN-VITRO
Jmw. Quinn et al., A COMBINATION OF OSTEOCLAST DIFFERENTIATION FACTOR AND MACROPHAGE-COLONY-STIMULATING FACTOR IS SUFFICIENT FOR BOTH HUMAN AND MOUSE OSTEOCLAST FORMATION IN-VITRO, Endocrinology, 139(10), 1998, pp. 4424-4427
Both human and murine osteoclasts can be derived in vitro from hematop
oietic cells or monocytes that are cocultured with osteoblasts or marr
ow-derived stromal cells. The osteoclastogenic stimulus provided by mu
rine osteoblasts and marrow-derived stromal cells is now known to be m
ediated by osteoclast differentiation factor (ODF), a membrane-bound t
umor necrosis factor-related ligand. This study demonstrates that mous
e spleen cells and monocytes form osteoclasts when cultured in the pre
sence of macrophage-colony stimulating factor (M-CSF) and a soluble fo
rm of murine ODF (sODF). Numerous multinucleated osteoclasts expressin
g tartrate resistant acid phosphatase (TRAP) and calcitonin receptor (
CTR) formed within 7 days of culture and engaged in extensive lacunar
bone resorption. Osteoclast number and bone resorption area was depend
ent on sODF concentration. Long-term cultured human monocytes also for
med bone resorbing osteoclasts in response to co-stimulation by sODF a
nd M-CSF, although this required more than 11 days in culture. This hu
man osteoclast differentiation was strongly inhibited by granulocyte-m
acrophage colony stimulating factor. This study further characterises
murine osteoclast differentiation caused by sODF and M-CSF co-stimulat
ion in vitro, and shows that the same co-stimulation causes human oste
oclast differentiation to occur. We propose that this methodology can
be employed to investigate the direct effects of cytokines and other f
actors on human osteoclast differentiation.